The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study to assess the safety and efficacy of autologous tumor infiltrating lymphocytes (lifileucel) with adjuvant pembrolizumab (PEMBRO) for treatment of immunotherapy naïve patients with high-risk clinical stage IIIb-d resectable melanoma (MEL).
 
James Isaacs
Research Funding - Bristol-Myers Squibb/Medarex (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); TScan Therapeutics (Inst); Vaxiion Therapeutics (Inst)
 
Lucy Kennedy
Research Funding - EpicentRx; IDEAYA Biosciences; Regeneron
 
Anthony Tufaro
No Relationships to Disclose
 
Mark DeLacure
No Relationships to Disclose
 
Anthony Visioni
No Relationships to Disclose
 
Eren Berber
No Relationships to Disclose
 
Daniel Raymond
Stock and Other Ownership Interests - Bristol-Myers Squibb; Zimmer Biomet
 
Paolo Caimi
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb; Genentech; Genmab; Incyte; Kite, a Gilead Company; Lilly; MEI Pharma; Novartis; Takeda
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Genentech (Inst); Luminary Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - XaTEC patent holder (I)
 
John Molina
Honoraria - Autolus Therapeutics; Cardinal Health; Jazz Pharmaceuticals; SOBI
Speakers' Bureau - Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Autolus Therapeutics; Cardinal Health
 
Yee Phoon
No Relationships to Disclose
 
Joshua Arbesman
Stock and Other Ownership Interests - Sanotize
Research Funding - Castle Biosciences; Variant Bio
 
Jennifer Ko
No Relationships to Disclose
 
Jan Melenhorst
No Relationships to Disclose
 
Joseph Skitzki
No Relationships to Disclose
 
Craig Sauter
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; crispr therapeutics; Gilead Sciences; Ipsen; Kite, a Gilead company; MorphoSys; Ono Pharmaceutical; Syncopation Life Sciences
Research Funding - Affimed Therapeutics; CARGO; Nkarta; Sanofi
 
Brian Gastman
Employment - Iovance Biotherapeutics
Stock and Other Ownership Interests - Castle Biosciences
Consulting or Advisory Role - Castle Biosciences; Quest Imaging
Speakers' Bureau - Castle Biosciences
Research Funding - Alkermes (Inst); Merck (Inst); NeoImmuneTech (Inst); Quest Imaging (Inst)
 
Thach-Giao Truong
Consulting or Advisory Role - Iovance Biotherapeutics; Merck; Novartis; Pfizer
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Castle Biosciences (Inst); Erasca, Inc (Inst); IDEAYA Biosciences (Inst); immatics (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Novartis; Perspective Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst)